Stryker Corp risk profile
38 Normal where most of the sector sits
Measured 1 September 2026 from SYK's filed statements. Recomputed nightly.
38 (Normal), driven by Competitive position at 48, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 29 | Normal | Stable | One-year price volatility — 28.1% |
| Operating pressure | 38 | Normal | Stable | Costs outgrowing revenue — +0.5 percentage points |
| Cash conversion | 20 | Normal | Stable | Capital spending against operating cash — 0.15x |
| Leverage and coverage | 27 | Normal | Stable | Net debt to EBITDA — 1.83x |
| Competitive position | 48 | Elevated | Stable | R&D-intensity gap against peers — -7.9 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.